Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.03 is 47% below its 5-year average of 15.14, near the low end of its 5-year range (8.03–32.65).
As of the fiscal period ended Tuesday, June 30, 2026. 8.57% below its 12-month average of 8.79.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.03.
CURRENT RATIO
8.03
CURRENT RATIO AVG TTM
8.79
CURRENT RATIO AVG 3Y
14.49
CURRENT RATIO AVG 5Y
15.14
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.57%
CURRENT VS 3Y AVG
-44.56%
CURRENT VS 5Y AVG
-46.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 732 covered companies
CURRENT VS SECTOR MEDIAN
+126.60%
vs the sector median at left
4D Molecular Therapeutics, Inc.
Market Cap
$670.70M
Current Ratio
8.03
TTM Avg
8.79
3Y Avg
14.49
5Y Avg
15.14
Market Cap
$689.73M
Current Ratio
14.20
TTM Avg
2.62
3Y Avg
2.46
5Y Avg
2.12
Market Cap
$637.17M
Current Ratio
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$642.27M
Current Ratio
14.16
TTM Avg
12.98
3Y Avg
15.39
5Y Avg
17.04
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | $670.70M | 8.03 | 8.79 | 14.49 | 15.14 |
| MiMedx Group, Inc. (MDXG)vs › | $669.77M | 5.33 | 4.27 | 3.79 | 3.57 |
| Annexon, Inc. (ANNX)vs › | $677.49M | 5.53 | 8.02 | 10.47 | 14.43 |
| Helus Pharma Inc. (HELP)vs › | $680.31M | 10.97 | 8.63 | 10.75 | 10.66 |
| Anteris Technologies Global Corp. (AVR)vs › | $689.73M | 14.20 | 2.62 | 2.46 | 2.12 |
| Aura Biosciences, Inc. (AURA)vs › | $637.17M | 16.82 | 9.46 | 14.12 | 14.05 |
| ArriVent BioPharma, Inc. (AVBP)vs › | $642.27M | 14.16 | 12.98 | 15.39 | 17.04 |
| Climb Bio, Inc. (CLYM)vs › | $633.33M | 31.45 | 23.29 | 26.88 | 23.21 |
| OmniAb, Inc. (OABI)vs › | $635.70M | 4.80 | 4.27 | 4.36 | 3.29 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $714.33M | 8.86 | 10.22 | 11.35 | 25.38 |
Current Ratio
8.03
Quick Ratio
8.03
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.03 |
| 2026-03-31 | 9.34 |
| 2025-12-31 | 9.39 |
| 2025-09-30 | 8.42 |
| 2025-06-30 | 8.75 |
| 2025-03-31 | 12.36 |
| 2024-12-31 | 14.92 |
| 2024-09-30 | 17.33 |
| 2024-06-30 | 28.48 |
| 2024-03-31 | 32.65 |
| 2023-12-31 | 15.65 |
| 2023-09-30 | 18.07 |
| 2023-06-30 | 23.11 |
| 2023-03-31 | 18.36 |
| 2022-12-31 | 14.02 |
| 2022-09-30 | 17.14 |
| 2022-06-30 | 17.20 |
| 2022-03-31 | 20.10 |
| 2021-12-31 | 15.69 |
| 2021-09-30 | 14.57 |
| 2021-06-30 | 25.20 |
| 2021-03-31 | 19.01 |
| 2020-12-31 | 16.88 |
| 2020-09-30 | 6.48 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 4.05 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 8.77 |
| 2019-03-31 | 8.77 |
| 2018-12-31 | 11.68 |
| 2018-09-30 | 11.68 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
